A Study on Disease Awareness and Treatment Compliance of Heart Failure Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-12

Study Completion Date

2021-09-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The AWARENESS HF-PD is a cross-sectional, multicenter, survey-based study. Cases who were admitted to the outpatient clinic and hospitalized with the diagnosis of Heart Failure (Acute and Chronic) will be included in the study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Multicenter Prospective Observational Study Evaluating the Management of Heart Failure

NCT05180370

Heart Failure

COMPLETED

Web-based Training and Telephone Follow-up of Patients With Heart Failure: Randomized Controlled Trial

NCT04210167

Heart Failure Patient Quality of Life +1 more

COMPLETED NA

ALERT-HF: Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure

NCT01813331

Chronic Heart Failure

COMPLETED

The Effect of Nurse-Led Education in Heart Failure Patients

NCT07032896

Heart Failure

NOT_YET_RECRUITING NA

Patient Journey in Hospital With Heart Failure in Turkish Population

NCT02487056

Heart Failure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data entry personnel to be assigned at the centers throughout the study will apply a questionnaire consisting of different questions to patients referred to them by clinicians with the diagnosis of HF. In addition, clinical features of HF from the current file of the cases (NYHA, comorbid conditions, comorbid diseases, blood pressure, heart rate, latest biochemistry (BNP/NTproBNP if available), hematology test results, most recent ECG, most recent echocardiography , coronary angiography report, if any) will be recorded. No additional examination/procedure will be performed for the study, only the data of the examinations requested by the clinician in routine clinical practice will be entered. A total of 200 patients from 3 centers will be included in this study over a six-month period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cases with the diagnosis of Heart Failure (Acute and Chronic)

Application of a questionnaire consisting of different questions to patients.

Questionnaires

Intervention Type OTHER

Application of a study based questionnaire described in the protocol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

Application of a study based questionnaire described in the protocol

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female patients aged 18 and over
2. Patients diagnosed with acute or chronic heart failure
3. Patients who agreed to participate in the study

Exclusion Criteria

1. Patients who stated that they did not agree to participate in the study
2. Patients who were not diagnosed with Heart Failure or whose diagnosis was changed or not confirmed during the index application
3. Pregnancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No